Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39117

DNAJB2 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

This product is a CRISPR/Cas9-edited polyclonal HEK293T cell population with targeted disruption of DNAJB2, a co-chaperone that cooperates with Hsc70 (HSPA8) to direct misfolded proteins to the ubiquitin-proteasome system and chaperone-mediated autophagy. Loss of DNAJB2 function models impaired protein quality control linked to Charcot-Marie-Tooth disease type 2T and other peripheral neuropathies. The knockout cells are suitable for investigating protein aggregation, proteasome activity, and autophagy, using techniques such as western blotting, co-immunoprecipitation, and immunofluorescence. They support mechanistic studies of neurodegeneration and screening for proteostasis-enhancing compounds.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DNAJB2

    Gene Identifier

    NCBI Gene ID 3300

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJB2 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNAJB2 gene has been disrupted in the HEK293T human embryonic kidney cell background. This product provides a heterogeneous pool of edited cells that facilitates loss-of-function studies of DNAJB2, encoding a co-chaperone critical for protein quality control. The polyclonal format avoids clonal selection artifacts and offers a robust model for interrogating chaperone-mediated processes without the confounding effects of single-cell bottlenecks.

HEK293T cells, derived from human embryonic kidney 293 cells stably expressing the SV40 large T antigen, are an adherent epithelial cell line widely employed for protein expression, lentiviral and retroviral packaging, and mechanistic investigations. Their high transfection efficiency and robust protein production make them an ideal host for creating knockout populations aimed at dissecting cellular pathways in a genetically tractable system. The HEK293T background enables seamless integration of the DNAJB2 knockout into existing workflows for protein homeostasis and neurobiology research.

DNAJB2 functions as a co-chaperone that interacts directly with Hsc70 (HSPA8) to modulate protein folding, refolding, and degradation. It recruits misfolded substrates to Hsc70 and, in concert with ubiquitin, BAG family proteins, and 26S proteasome subunits, tags clients for proteasomal destruction. DNAJB2 also participates in chaperone-mediated autophagy by facilitating substrate translocation through LAMP2A. Its expression is regulated by heat shock factor 1 (HSF1) and cellular stress signals, while its activity impacts the unfolded protein response and ER-associated degradation pathways. Loss of DNAJB2 disrupts this network, leading to accumulation of aggregation-prone proteins.

In the HEK293T context, depletion of DNAJB2 creates a model for studying proteostasis failure and its downstream neurotoxic consequences. This knockout is directly relevant to peripheral neuropathies, including Charcot-Marie-Tooth disease type 2T and distal hereditary motor neuropathy, where DNAJB2 mutations compromise neuronal protein quality control. The cell population allows researchers to examine how impaired co-chaperone function affects ubiquitin-proteasome system activity, autophagy flux, and cellular vulnerability to proteotoxic stress, providing insights into the molecular underpinnings of neurodegeneration.

Researchers can employ this polyclonal knockout model in diverse applications, including western blotting and co-immunoprecipitation to assess DNAJB2 and HSPA8 interactions, proteasome activity assays to measure degradation capacity, and immunofluorescence staining to visualize protein aggregates. Cell viability assays under proteotoxic insult, autophagy flux reporters, and flow cytometry for apoptotic markers further enable detailed phenotypic characterization. Small-molecule screens aimed at enhancing proteostasis or restoring protein clearance can also be conducted. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)